Trust Company of Vermont’s Allergan plc AGN.PRA Stock Holding History

Trust Company of Vermont’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20	Closed	-$12K	–	1016
2017 Q4	$12K	Buy	+20	New	+$12.9K	﹤0.01%	737

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Trust Company of Vermont's AGN.PRA Position: Q1 2018 in Review

Trust Company of Vermont sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 20 shares — an estimated $12K sold.

Trust Company of Vermont first reported a position in AGN.PRA in Q4 2017 and held it in 1 quarter. The position peaked at $12K in Q4 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Trust Company of Vermont reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Trust Company of Vermont sold 20 Allergan plc shares in Q1 2018, an estimated $12K.
Trust Company of Vermont first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Trust Company of Vermont's Allergan plc position peaked at $12K in Q4 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Trust Company of Vermont's 13F filing for Q1 2018, filed 18 May 2018.